|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||
15 May 2007 | Volume 146 Issue 10 | Pages 699-706
Background: Longer-term mortality benefit and cost-effectiveness for abdominal aortic aneurysm (AAA) screening are uncertain.
Objective: To estimate the benefits, in terms of AAA-related and all-cause mortality, and cost-effectiveness of ultrasonography screening for AAA in a group that was invited to screening compared with a group that was not invited at a mean 7-year follow-up.
Design: Randomized trial.
Setting: 4 centers in the United Kingdom.
Patients: Population-based sample of 67 770 men age 65 to 74 years.
Intervention: Patients with an AAA detected at screening had surveillance and were offered surgery after predefined criteria were met.
Measurements: Mortality data were obtained after flagging on the national database. Unit costs obtained from large samples were applied to individual event data for the cost analysis.
Results: The hazard ratio was 0.53 (95% CI, 0.42 to 0.68) for AAA-related mortality in the group invited for screening. The rupture rate in men with normal results on initial ultrasonography has remained low: 0.54 rupture (CI, 0.25 to 1.02 ruptures) per 10 000 person-years. In terms of all-cause mortality, the observed hazard ratio was 0.96 (CI, 0.93 to 1.00). At the 7-year follow-up, cost-effectiveness was estimated at $19 500 (CI, $12 400 to $39 800) per life-year gained based on AAA-related mortality and $7600 (CI, $3300 to
Limitation: Inclusion of deaths from aortic aneurysm at an unspecified site, which may include some thoracic aortic aneurysms, may have underestimated the treatment effect.
Conclusions: These results from a large, pragmatic randomized trial show that the early mortality benefit of screening ultrasonography for AAA is maintained in the longer term and that the cost-effectiveness of screening improves over time.
International Standard Randomized Controlled Trial registration number: ISRCTN37381646.
Editors' Notes
Context
Contribution
Cautions
The Editors
Author and Article Information
From the Institute of Public Health, Cambridge, United Kingdom, and St. Richard's Hospital, Chichester, United Kingdom.
Acknowledgment: The authors thank Professor Martin Buxton for comments on a previous version of this paper.
Grant Support: By the U.K. Medical Research Council. Ms. Kim receives a Raymond and Beverly Sackler Studentship Award.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Lois G. Kim, MSc, MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, United Kingdom; e-mail, lois.kim{at}mrc-bsu.cam.ac.uk.
Current Author Addresses: Ms. Kim and Dr. Thompson: MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge CB2 2SR, United Kingdom.
Mr. Scott and Ms. Ashton: Scott Research Unit, Chichester Medical Education Centre, St. Richard's Hospital, Spitalfield Lane, Chichester PO19 6SE, United Kingdom.
Author Contributions: Conception and design: R.A.P. Scott, H.A. Ashton.
Analysis and interpretation of the data: L.G. Kim, R.A.P. Scott, H.A. Ashton, S.G. Thompson.
Drafting of the article: L.G. Kim, R.A.P. Scott, H.A. Ashton.
Critical revision of the article for important intellectual content: L.G. Kim, R.A.P. Scott, S.G. Thompson.
Final approval of the article: L.G. Kim, R.A.P. Scott, H.A. Ashton, S.G. Thompson.
Statistical expertise: L.G. Kim, S.G. Thompson.
Obtaining of funding: R.A.P. Scott, S.G. Thompson.
Administrative, technical, or logistic support: R.A.P. Scott, H.A. Ashton.
Collection and assembly of data: R.A.P. Scott, H.A. Ashton. ARTICLE
A Sustained Mortality Benefit from Screening for Abdominal Aortic Aneurysm
) per life-year gained based on all-cause death. (All values are reported in U.S. dollars [U.K. £1 = U.S. $1.58]).
![]()
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
M. J Buxton Screening for abdominal aortic aneurysm BMJ, June 24, 2009; 338(jun24_2): b2185 - b2185. [Full Text] |
||||
![]() |
S G Thompson, H A Ashton, L Gao, R A P Scott, and on behalf of the Multicentre Aneurysm Screening St Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study BMJ, June 24, 2009; 338(jun24_2): b2307 - b2307. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bierig and A. Jones Accuracy and Cost Comparison of Ultrasound Versus Alternative Imaging Modalities, Including CT, MR, PET, and Angiography Journal of Diagnostic Medical Sonography, May 1, 2009; 25(3): 138 - 144. [Abstract] [PDF] |
||||
![]() |
M. A. Hlatky and P. A. Heidenreich The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., April 21, 2009; 53(16): 1459 - 1466. [Full Text] [PDF] |
||||
![]() |
M. Ashraf Mansour and R. M. Zwolak Office-Based Vascular Lab: Is It Worth the Effort? Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2009; 21(1): 5 - 8. [Abstract] [PDF] |
||||
![]() |
M. H. Criqui, M. J. Alberts, F. G. R. Fowkes, A. T. Hirsch, P. T. O'Gara, J. W. Olin, and for Writing Group 2 Atherosclerotic Peripheral Vascular Disease Symposium II: Screening for Atherosclerotic Vascular Diseases:: Should Nationwide Programs Be Instituted? Circulation, December 16, 2008; 118(25): 2830 - 2836. [Full Text] [PDF] |
||||
![]() |
M. A. Hlatky Expanding the Orbit of Primary Prevention -- Moving beyond JUPITER N. Engl. J. Med., November 20, 2008; 359(21): 2280 - 2282. [Full Text] [PDF] |
||||
![]() |
H. Hafez Abdominal aortic aneurysm disease: health risks, management and screening Clin Risk, November 1, 2008; 14(6): 208 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brearley Should we screen for abdominal aortic aneurysm? Yes BMJ, April 19, 2008; 336(7649): 862 - 862. [Full Text] [PDF] |
||||
![]() |
J. Sanz, P. R. Moreno, and V. Fuster The year in atherothrombosis. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955. [Full Text] [PDF] |
||||
![]() |
M. S. Freiberg, A. M. Arnold, A. B. Newman, M. S. Edwards, K. L. Kraemer, and L. H. Kuller Abdominal Aortic Aneurysms, Increasing Infrarenal Aortic Diameter, and Risk of Total Mortality and Incident Cardiovascular Disease Events: 10-Year Follow-Up Data From the Cardiovascular Health Study Circulation, February 26, 2008; 117(8): 1010 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takagi, N. Kawai, and T. Umemoto Screening reduces all cause mortality in men BMJ, November 3, 2007; 335(7626): 899 - 899. [Full Text] [PDF] |
||||
![]() |
R. Greenhalgh and J. Powell Screening for abdominal aortic aneurysm BMJ, October 13, 2007; 335(7623): 732 - 733. [Full Text] [PDF] |
||||
![]() |
R. Lehman Evidently... Evid. Based Med., October 1, 2007; 12(5): 135 - 135. [Full Text] [PDF] |
||||
![]() |
Correction: A Sustained Mortality Benefit from Screening for Abdominal Aortic Aneurysm Ann Intern Med, August 7, 2007; 147(3): 216 - 216. [Full Text] [PDF] |
||||
![]() |
Screening and Management of Abdominal Aortic Aneurysm Journal Watch (General), June 7, 2007; 2007(607): 1 - 1. [Full Text] |
||||
![]() |
J. D. Birkmeyer and G. R. Upchurch Jr. Evidence-Based Screening and Management of Abdominal Aortic Aneurysm Ann Intern Med, May 15, 2007; 146(10): 749 - 750. [Full Text] [PDF] |
||||
Read all Rapid Responses